Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Membrane Fusion | 15 | 2016 | 28 | 2.890 |
Why?
|
| Cell Membrane | 12 | 2018 | 105 | 2.470 |
Why?
|
| Membrane Lipids | 11 | 2016 | 16 | 2.420 |
Why?
|
| Models, Biological | 11 | 2016 | 343 | 1.790 |
Why?
|
| Lipid Bilayers | 10 | 2016 | 52 | 1.690 |
Why?
|
| Viral Fusion Proteins | 7 | 2020 | 16 | 1.620 |
Why?
|
| Models, Chemical | 6 | 2016 | 42 | 1.330 |
Why?
|
| Membrane Microdomains | 5 | 2008 | 15 | 1.260 |
Why?
|
| Virus Internalization | 7 | 2021 | 17 | 1.240 |
Why?
|
| HIV-1 | 6 | 2011 | 438 | 1.090 |
Why?
|
| HIV Envelope Protein gp41 | 4 | 2011 | 12 | 1.000 |
Why?
|
| Membrane Fluidity | 4 | 2008 | 6 | 0.980 |
Why?
|
| Light | 4 | 2011 | 76 | 0.880 |
Why?
|
| Intestinal Mucosa | 3 | 2011 | 220 | 0.870 |
Why?
|
| Cholesterol | 4 | 2018 | 50 | 0.770 |
Why?
|
| Models, Molecular | 5 | 2011 | 81 | 0.750 |
Why?
|
| Membrane Proteins | 5 | 2019 | 173 | 0.750 |
Why?
|
| Viral Envelope Proteins | 5 | 2021 | 21 | 0.710 |
Why?
|
| Ebolavirus | 2 | 2016 | 5 | 0.700 |
Why?
|
| Precancerous Conditions | 2 | 2010 | 22 | 0.660 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2011 | 81 | 0.660 |
Why?
|
| Erythrocytes | 2 | 2018 | 20 | 0.660 |
Why?
|
| Membrane Potentials | 2 | 2010 | 189 | 0.650 |
Why?
|
| beta-Cyclodextrins | 1 | 2018 | 4 | 0.650 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 329 | 0.610 |
Why?
|
| Algorithms | 8 | 2008 | 400 | 0.580 |
Why?
|
| Cells | 1 | 2016 | 4 | 0.570 |
Why?
|
| Viruses | 1 | 2016 | 7 | 0.570 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2016 | 7 | 0.560 |
Why?
|
| Cell Line | 9 | 2015 | 298 | 0.550 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 11 | 0.550 |
Why?
|
| Thermodynamics | 5 | 2018 | 42 | 0.510 |
Why?
|
| Water | 2 | 2011 | 34 | 0.490 |
Why?
|
| Animals | 16 | 2021 | 4552 | 0.480 |
Why?
|
| Viral Proteins | 2 | 2013 | 24 | 0.480 |
Why?
|
| Mechanical Phenomena | 1 | 2013 | 22 | 0.480 |
Why?
|
| Cell Fusion | 3 | 2010 | 8 | 0.470 |
Why?
|
| Endosomes | 3 | 2021 | 8 | 0.460 |
Why?
|
| Peptide Fragments | 2 | 2011 | 99 | 0.440 |
Why?
|
| Protein Transport | 2 | 2019 | 38 | 0.440 |
Why?
|
| Gene Products, env | 3 | 2009 | 13 | 0.430 |
Why?
|
| Hydrogen-Ion Concentration | 8 | 2016 | 148 | 0.430 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 4 | 2016 | 11 | 0.420 |
Why?
|
| Microfluidics | 1 | 2011 | 8 | 0.420 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 2 | 0.410 |
Why?
|
| Fiber Optic Technology | 1 | 2011 | 5 | 0.400 |
Why?
|
| Epithelium | 1 | 2011 | 26 | 0.400 |
Why?
|
| Endocytosis | 1 | 2011 | 17 | 0.400 |
Why?
|
| Liposomes | 5 | 2016 | 13 | 0.390 |
Why?
|
| Carcinoma in Situ | 1 | 2010 | 9 | 0.390 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2004 | 219 | 0.380 |
Why?
|
| HEK293 Cells | 5 | 2021 | 70 | 0.370 |
Why?
|
| Anti-HIV Agents | 1 | 2011 | 169 | 0.370 |
Why?
|
| Colonic Neoplasms | 2 | 2011 | 66 | 0.370 |
Why?
|
| CD4 Antigens | 4 | 2005 | 35 | 0.370 |
Why?
|
| Porosity | 3 | 2016 | 71 | 0.360 |
Why?
|
| Colorectal Neoplasms | 1 | 2010 | 82 | 0.360 |
Why?
|
| Humans | 26 | 2021 | 29337 | 0.360 |
Why?
|
| Scattering, Radiation | 6 | 2011 | 39 | 0.350 |
Why?
|
| Stochastic Processes | 4 | 2011 | 12 | 0.350 |
Why?
|
| HIV | 1 | 2009 | 92 | 0.340 |
Why?
|
| Photometry | 1 | 2008 | 1 | 0.340 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2008 | 10 | 0.330 |
Why?
|
| Computer Simulation | 5 | 2011 | 218 | 0.330 |
Why?
|
| Protein Folding | 2 | 2005 | 18 | 0.320 |
Why?
|
| Semliki forest virus | 1 | 2007 | 2 | 0.310 |
Why?
|
| Virion | 4 | 2020 | 13 | 0.310 |
Why?
|
| Brain Mapping | 2 | 1998 | 195 | 0.300 |
Why?
|
| Biophysics | 1 | 2007 | 38 | 0.300 |
Why?
|
| Brain | 3 | 2004 | 1689 | 0.290 |
Why?
|
| Lipid Peroxides | 1 | 2006 | 2 | 0.290 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2006 | 222 | 0.280 |
Why?
|
| Flow Cytometry | 3 | 2016 | 198 | 0.280 |
Why?
|
| Spectrum Analysis | 1 | 2006 | 9 | 0.280 |
Why?
|
| Energy Transfer | 3 | 2004 | 5 | 0.280 |
Why?
|
| COS Cells | 5 | 2021 | 40 | 0.270 |
Why?
|
| Colitis | 1 | 2006 | 37 | 0.270 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2005 | 19 | 0.270 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 11 | 0.270 |
Why?
|
| Influenza A virus | 4 | 2019 | 20 | 0.270 |
Why?
|
| Diagnostic Imaging | 1 | 2006 | 90 | 0.260 |
Why?
|
| Ultrasonography, Mammary | 4 | 2008 | 8 | 0.260 |
Why?
|
| Lipids | 3 | 2011 | 36 | 0.250 |
Why?
|
| Nonlinear Dynamics | 1 | 2004 | 14 | 0.250 |
Why?
|
| Lassa virus | 2 | 2021 | 4 | 0.250 |
Why?
|
| Protein Conformation | 7 | 2008 | 69 | 0.250 |
Why?
|
| Orthomyxoviridae | 2 | 2001 | 3 | 0.250 |
Why?
|
| Temperature | 4 | 2007 | 76 | 0.240 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 193 | 0.230 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 246 | 0.220 |
Why?
|
| Molecular Conformation | 3 | 2008 | 15 | 0.220 |
Why?
|
| Rats | 5 | 2011 | 854 | 0.210 |
Why?
|
| Lassa Fever | 1 | 2021 | 2 | 0.210 |
Why?
|
| Monoglycerides | 1 | 2021 | 2 | 0.210 |
Why?
|
| Lysophospholipids | 1 | 2021 | 3 | 0.210 |
Why?
|
| Antiviral Agents | 2 | 2020 | 132 | 0.200 |
Why?
|
| Mutation | 3 | 2016 | 383 | 0.200 |
Why?
|
| Sensitivity and Specificity | 4 | 2011 | 553 | 0.190 |
Why?
|
| Colicins | 4 | 1995 | 5 | 0.190 |
Why?
|
| Elasticity | 3 | 2015 | 39 | 0.190 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 5 | 0.190 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 5 | 0.190 |
Why?
|
| RNA Viruses | 1 | 2020 | 5 | 0.190 |
Why?
|
| Salicylates | 1 | 2020 | 7 | 0.190 |
Why?
|
| DNA Viruses | 1 | 2020 | 6 | 0.190 |
Why?
|
| Fluorescent Dyes | 4 | 2010 | 54 | 0.180 |
Why?
|
| Ultrasonography | 1 | 2001 | 226 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 22 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 145 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 101 | 0.160 |
Why?
|
| Models, Statistical | 2 | 2008 | 132 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 2 | 2008 | 9 | 0.150 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 115 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 61 | 0.150 |
Why?
|
| Ion Channels | 3 | 1995 | 189 | 0.140 |
Why?
|
| Membranes | 1 | 2016 | 9 | 0.140 |
Why?
|
| Hemagglutinins | 1 | 1996 | 1 | 0.140 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 166 | 0.140 |
Why?
|
| Cathepsins | 1 | 2016 | 7 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 78 | 0.140 |
Why?
|
| Blotting, Western | 1 | 2016 | 170 | 0.140 |
Why?
|
| Signal Transduction | 1 | 2018 | 482 | 0.130 |
Why?
|
| Detergents | 2 | 2007 | 4 | 0.130 |
Why?
|
| Exocytosis | 2 | 1993 | 4 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 391 | 0.130 |
Why?
|
| Mice | 4 | 2008 | 1607 | 0.120 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2013 | 5 | 0.120 |
Why?
|
| Surface Tension | 2 | 2015 | 3 | 0.120 |
Why?
|
| Time Factors | 2 | 2010 | 1616 | 0.120 |
Why?
|
| Protein Structure, Secondary | 2 | 2011 | 19 | 0.120 |
Why?
|
| Phantoms, Imaging | 2 | 2010 | 42 | 0.110 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 20 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 26 | 0.110 |
Why?
|
| Kinetics | 3 | 2009 | 225 | 0.110 |
Why?
|
| Reproducibility of Results | 4 | 2008 | 788 | 0.110 |
Why?
|
| Virus Replication | 2 | 2020 | 92 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2006 | 96 | 0.110 |
Why?
|
| Viscosity | 1 | 2011 | 10 | 0.110 |
Why?
|
| Friction | 1 | 2011 | 20 | 0.110 |
Why?
|
| Diffusion | 1 | 2011 | 28 | 0.110 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2011 | 1 | 0.100 |
Why?
|
| Entropy | 1 | 2011 | 5 | 0.100 |
Why?
|
| Protein Stability | 1 | 2011 | 7 | 0.100 |
Why?
|
| Biomechanical Phenomena | 1 | 2013 | 668 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 45 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2011 | 63 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 37 | 0.100 |
Why?
|
| Peptides | 2 | 2009 | 95 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 85 | 0.100 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 38 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 50 | 0.100 |
Why?
|
| Fluorescence | 1 | 2010 | 12 | 0.090 |
Why?
|
| Electricity | 1 | 2010 | 9 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2010 | 65 | 0.090 |
Why?
|
| Rabbits | 1 | 2011 | 280 | 0.090 |
Why?
|
| Biopsy | 1 | 2011 | 234 | 0.090 |
Why?
|
| Mutagenesis | 1 | 2009 | 12 | 0.090 |
Why?
|
| Electrophysiology | 2 | 2007 | 129 | 0.090 |
Why?
|
| Image Enhancement | 2 | 2008 | 57 | 0.090 |
Why?
|
| Intracellular Membranes | 2 | 2007 | 32 | 0.090 |
Why?
|
| Radio Waves | 3 | 2008 | 8 | 0.080 |
Why?
|
| Wettability | 1 | 2008 | 1 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1998 | 451 | 0.080 |
Why?
|
| Receptors, CCR5 | 2 | 2005 | 27 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2005 | 50 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2006 | 24 | 0.080 |
Why?
|
| Carcinoma, Ductal | 1 | 2008 | 3 | 0.080 |
Why?
|
| Reference Values | 2 | 1998 | 227 | 0.080 |
Why?
|
| Receptors, CXCR4 | 2 | 2005 | 27 | 0.080 |
Why?
|
| Electric Capacitance | 1 | 2007 | 5 | 0.080 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 56 | 0.080 |
Why?
|
| Permeability | 1 | 2007 | 134 | 0.080 |
Why?
|
| Anisotropy | 1 | 2007 | 58 | 0.070 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 340 | 0.070 |
Why?
|
| Phosphatidylethanolamines | 1 | 2006 | 2 | 0.070 |
Why?
|
| Photobleaching | 1 | 2006 | 3 | 0.070 |
Why?
|
| Sphingomyelins | 1 | 2006 | 5 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 12 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2006 | 44 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 73 | 0.070 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2005 | 3 | 0.070 |
Why?
|
| Gene Deletion | 1 | 2005 | 40 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 44 | 0.060 |
Why?
|
| Cryoultramicrotomy | 1 | 2004 | 2 | 0.060 |
Why?
|
| Biomedical Engineering | 2 | 2001 | 6 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2004 | 25 | 0.060 |
Why?
|
| Female | 4 | 2018 | 16197 | 0.060 |
Why?
|
| Hemorrhoids | 1 | 2001 | 1 | 0.050 |
Why?
|
| HIV Infections | 1 | 2009 | 970 | 0.050 |
Why?
|
| Micelles | 1 | 2001 | 1 | 0.050 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2001 | 1 | 0.050 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2001 | 3 | 0.050 |
Why?
|
| Vero Cells | 1 | 2020 | 7 | 0.050 |
Why?
|
| DNA Replication | 1 | 2020 | 12 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2020 | 96 | 0.050 |
Why?
|
| Point Mutation | 1 | 1999 | 30 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 9 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 13 | 0.040 |
Why?
|
| Optical Imaging | 1 | 2019 | 7 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 22 | 0.040 |
Why?
|
| Artifacts | 1 | 1998 | 32 | 0.040 |
Why?
|
| Biological Transport | 3 | 1995 | 43 | 0.040 |
Why?
|
| Astrocytes | 1 | 2020 | 122 | 0.040 |
Why?
|
| Species Specificity | 1 | 1998 | 70 | 0.040 |
Why?
|
| Models, Neurological | 1 | 1998 | 30 | 0.040 |
Why?
|
| Lysophosphatidylcholines | 1 | 1997 | 7 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 1997 | 4 | 0.040 |
Why?
|
| Physical Phenomena | 1 | 2016 | 3 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2015 | 7 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 2015 | 5 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 55 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 97 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2015 | 101 | 0.030 |
Why?
|
| Male | 3 | 2001 | 15621 | 0.030 |
Why?
|
| Pulmonary Adenomatosis, Ovine | 1 | 2013 | 2 | 0.030 |
Why?
|
| Jaagsiekte sheep retrovirus | 1 | 2013 | 2 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 13 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2013 | 19 | 0.030 |
Why?
|
| Mast Cells | 1 | 1993 | 26 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 36 | 0.030 |
Why?
|
| Sheep | 1 | 2013 | 39 | 0.030 |
Why?
|
| Potassium | 1 | 1992 | 67 | 0.030 |
Why?
|
| ROC Curve | 2 | 2003 | 138 | 0.030 |
Why?
|
| Rhodamines | 1 | 1991 | 5 | 0.030 |
Why?
|
| Video Recording | 1 | 1991 | 47 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 1990 | 9 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1990 | 76 | 0.020 |
Why?
|
| Gene Products, gag | 1 | 2005 | 4 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 34 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 29 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2005 | 30 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 22 | 0.020 |
Why?
|
| Kidney | 1 | 2005 | 173 | 0.020 |
Why?
|
| Quality Control | 1 | 2003 | 43 | 0.010 |
Why?
|
| Proctoscopy | 1 | 2001 | 1 | 0.010 |
Why?
|
| Proctoscopes | 1 | 2001 | 1 | 0.010 |
Why?
|
| Arteries | 1 | 2001 | 17 | 0.010 |
Why?
|
| Ligation | 1 | 2001 | 32 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 521 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2001 | 4 | 0.010 |
Why?
|
| Fibroadenoma | 1 | 2001 | 3 | 0.010 |
Why?
|
| Escherichia coli | 2 | 1991 | 59 | 0.010 |
Why?
|
| Suture Techniques | 1 | 2001 | 141 | 0.010 |
Why?
|
| Chlorpromazine | 1 | 1999 | 11 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1999 | 11 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1999 | 31 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 355 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1997 | 8 | 0.010 |
Why?
|
| Fluorometry | 1 | 1997 | 5 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1997 | 28 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1997 | 3 | 0.010 |
Why?
|
| Gangliosides | 1 | 1997 | 6 | 0.010 |
Why?
|
| Cobalt | 1 | 1997 | 116 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 1995 | 14 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 127 | 0.010 |
Why?
|
| Freeze Fracturing | 1 | 1993 | 1 | 0.010 |
Why?
|
| Peritoneal Cavity | 1 | 1993 | 3 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 1993 | 9 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 1993 | 7 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1993 | 70 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1993 | 74 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 4851 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 432 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 16 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1991 | 16 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1991 | 19 | 0.010 |
Why?
|
| Plasmids | 1 | 1991 | 44 | 0.010 |
Why?
|
| Papain | 1 | 1990 | 1 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1990 | 3 | 0.010 |
Why?
|
| Glucosides | 1 | 1990 | 4 | 0.010 |
Why?
|
| Acrylamides | 1 | 1990 | 5 | 0.010 |
Why?
|
| Adult | 1 | 2001 | 8601 | 0.010 |
Why?
|
| Middle Aged | 1 | 2001 | 9823 | 0.000 |
Why?
|
| Aged | 1 | 2001 | 9448 | 0.000 |
Why?
|